cbdMD, Inc. (YCBD) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

cbdMD, Inc. (YCBD) closed at USD 0.35 on 2026-10-14, a change of -65.7 % over the past year, with a market capitalization of USD 4.03M.

cbdMD, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

cbdMD, Inc. key figures

Previous close

USD 0.35 (2026-10-14)

1-year change

-65.7 %

Market cap

USD 4.03M

Enterprise value

USD 4.13M

P/E ratio (trailing)

1.57

P/E ratio (forward)

-0.40

EPS (trailing)

0.23

EPS (forward)

-0.89

PEG ratio

n/a

Price to book

0.49

Revenue growth

20.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.67

Employees

42

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About cbdMD, Inc.

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for cbdMD, Inc. and compare it with other stocks.